David Kandzari

David Kandzari

Director of Interventional Cardiology and Chief Scientific Officer

Piedmont Heart Institute, Atlanta, GA, USA

  • LinkedIn
  • X

Biography

Dr David Kandzari obtained his undergraduate degree from Duke University School of Medicine then completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. 

Dr Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews. Dr Kandzari is board certified in internal medicine and cardiovascular diseases and is certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His clinical focus includes catheter-based revascularization of complex coronary and peripheral disease.

Read more

Media

David Kandzari,

Watch time: 7m 14s

David Kandzari,

Watch time: 6m 46s
AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension

David Kandzari,

Watch time: 10m 6s
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG

David Kandzari,

Watch time: 10m 19s

William Fearon, Matthias Gotberg, Rafael Romaguera, et al

Watch time: 2h 1m 45s (13 videos)

Darren Mylotte, Marie-Claude Morice, Roisin Colleran, et al

Watch time: 28m 31s (3 videos)
EuroPCR 2018: SPYRAL HTN-ON MED

Justin E Davies, David Kandzari,

Watch time: 18m 11s
ESC 2017: BIO-FLOW V -Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent - Full Interview

David Kandzari,

Watch time: 6m 10s
BIO-FLOW V - Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent - Highlights

David Kandzari,

Watch time: 1m 51s

Articles by David Kandzari, Director of Interventional Cardiology and Chief Scientific Officer

Percutaneous Treatment of Coronary Chronic Total Occlusion Part 2: Technical Approach

Alfredo Galassi, Aaron Grantham, David Kandzari, et al

Citation: Interventional Cardiology Review 2014;9(3):201–7

DOI:

https://doi.org/10.15420/icr.2014.9.3.201
Percutaneous Treatment of Coronary Chronic Total Occlusions Part 1: Rationale and Outcomes

Alfredo Galassi, Aaron Grantham, David Kandzari, et al

Citation: Interventional Cardiology Review 2014;9(3):195–200

DOI:

https://doi.org/10.15420/icr.2014.9.3.195
Stent Thrombosis Associated with First-generation Drug-eluting Stents - Issues with Antiplatelet Therapy

Paul A Gurbel, David Kandzari,

Citation: European Cardiovascular Disease 2006;2(2):45–9

DOI:

https://doi.org/10.15420/ecr.2006.0.2.45
Drug-eluting Stent Utilisation and Outcomes in Acute Coronary Syndromes – Evidence-based Practice Without the Evidence?

Pantelis Diamantouros, David Kandzari,

Citation: Interventional Cardiology 2006;1(1):33–4

DOI:

https://doi.org/10.15420/icr.2006.1.1.33